Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Jung

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
BMC Cancer|July 23, 2009
Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?Angelika Tölle, Monika Jung, Michael Lein, et al.
Urologic Oncology|January 2, 2009
MicroRNAs and cancer: current state and future perspectives in urologic oncologyAnnika Schaefer, Monika Jung, Glen Kristiansen, et al.
BMC Urology|February 5, 2020
Limited utility of qPCR-based detection of tumor-specific circulating mRNAs in whole blood from clear cell renal cell carcinoma patientsSinisa Simonovic, Christian Hinze, Kai M Schmidt-Ott, et al.
The Prostate|March 28, 2003
mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissueMonika Jung, Andreas Römer, Gernot Keyszer, et al.
Cancers|October 24, 2019
A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue SignatureZhongwei Zhao, Sabine Weickmann, Monika Jung, et al.
The Prostate|September 25, 2004
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomyChuanliang Xu, Monika Jung, Mick Burkhardt, et al.
Theranostics|August 18, 2020
Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to realityHannah Rochow, Antonia Franz, Monika Jung, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2015
Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomasJonas Busch, Bernhard Ralla, Monika Jung, et al.
European Urology|June 30, 2006
Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomyAnja Rabien, Mick Burkhardt, Monika Jung, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2006
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosisFlorian R Fritzsche, Monika Jung, Chuanliang Xu, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
BMC Cancer|July 23, 2009
Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?Angelika Tölle, Monika Jung, Michael Lein, et al.
Urologic Oncology|January 2, 2009
MicroRNAs and cancer: current state and future perspectives in urologic oncologyAnnika Schaefer, Monika Jung, Glen Kristiansen, et al.
BMC Urology|February 5, 2020
Limited utility of qPCR-based detection of tumor-specific circulating mRNAs in whole blood from clear cell renal cell carcinoma patientsSinisa Simonovic, Christian Hinze, Kai M Schmidt-Ott, et al.
The Prostate|March 28, 2003
mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissueMonika Jung, Andreas Römer, Gernot Keyszer, et al.
Cancers|October 24, 2019
A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue SignatureZhongwei Zhao, Sabine Weickmann, Monika Jung, et al.
The Prostate|September 25, 2004
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomyChuanliang Xu, Monika Jung, Mick Burkhardt, et al.
Theranostics|August 18, 2020
Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to realityHannah Rochow, Antonia Franz, Monika Jung, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2015
Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomasJonas Busch, Bernhard Ralla, Monika Jung, et al.
European Urology|June 30, 2006
Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomyAnja Rabien, Mick Burkhardt, Monika Jung, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2006
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosisFlorian R Fritzsche, Monika Jung, Chuanliang Xu, et al.
Pageof 5